DrugPatentWatch Database Preview
Investigational Drug Information for Batefenterol
Email this page to a colleague
What is the development status for investigational drug Batefenterol?
Batefenterol is an investigational drug.
There have been 4 clinical trials for Batefenterol.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Chronic Disease, Pulmonary Disease, Chronic Obstructive, and Lung Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Hammersmith Medicines Research, and Theravance Biopharma.
There are seventeen US patents protecting this investigational drug and two hundred and forty international patents.
Summary for Batefenterol
| US Patents | 17 |
| International Patents | 240 |
| US Patent Applications | 50 |
| WIPO Patent Applications | 23 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 2 (2015-12-01) |
| Vendors | 30 |
Recent Clinical Trials for Batefenterol
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | GlaxoSmithKline | Phase 1 |
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | Hammersmith Medicines Research | Phase 1 |
| A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | Theravance Biopharma | Phase 1 |
Clinical Trial Summary for Batefenterol
Top disease conditions for Batefenterol
Top clinical trial sponsors for Batefenterol
US Patents for Batefenterol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Batefenterol | ⤷ Try it Free | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | Fused imidazo-piperidine JAK inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | Methods of treatment using a JAK inhibitor compound | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | Fused imidazo-piperidine JAK inhibitors | Theravance Biopharma R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | Methods of treatment using a JAK inhibitor compound | Theravance Biopharma R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Batefenterol | ⤷ Try it Free | JAK inhibitors containing a 4-membered heterocyclic amide | Theravance Biopharma R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Batefenterol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Batefenterol | Argentina | AR111241 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Argentina | AR111242 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Australia | AU2018231032 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Australia | AU2018231035 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Brazil | BR112019018648 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Brazil | BR112019018649 | 2037-03-09 | ⤷ Try it Free |
| Batefenterol | Canada | CA2997772 | 2037-03-09 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
